NPPA Revises Price of Anti-rabies Immunoglobulin; Fixes Rates for Heart, Diabetes, HIV and Eye Drugs
The National Pharmaceutical Pricing Authority (NPPA) has increased the retail price of anti-rabies immunoglobulin by 6.49% and fixed the retail prices of 39 new drug formulations used to treat hypertension, diabetes, HIV, cardiovascular diseases, eye …